R
Robert M. Kotloff
Researcher at Cleveland Clinic
Publications - 131
Citations - 8248
Robert M. Kotloff is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Lung transplantation & Transplantation. The author has an hindex of 42, co-authored 130 publications receiving 7445 citations. Previous affiliations of Robert M. Kotloff include University of Pennsylvania & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.
Jonathan B. Orens,Marc Estenne,Selim M. Arcasoy,John V. Conte,Paul A. Corris,Jim J. Egan,Thomas M. Egan,Shaf Keshavjee,Christiane Knoop,Robert M. Kotloff,Fernando J. Martinez,Steven D. Nathan,Scott M. Palmer,A. Patterson,Lianne G. Singer,Gregory I Snell,Sean M. Studer,Jean-Luc Vachiery,Allan R. Glanville +18 more
TL;DR: This update to the international guidelines is based primarily on a consensus of opinion rendered by experts in the field and should not be considered to be hard and fast rules.
Journal ArticleDOI
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.
Selim M. Arcasoy,Jason D. Christie,Victor A. Ferrari,Martin St. John Sutton,David A. Zisman,Nancy P. Blumenthal,Alberto Pochettino,Robert M. Kotloff +7 more
TL;DR: Estimation of systolic pulmonary artery pressure by echocardiography is frequently inaccurate in patients with advanced lung disease and leads to considerable overdiagnosis of pulmonary hypertension.
Journal ArticleDOI
Primary Graft Failure Following Lung Transplantation
Jason D. Christie,Joseph E. Bavaria,Harold I. Palevsky,Leslie A. Litzky,Nancy P. Blumenthal,Larry R. Kaiser,Robert M. Kotloff +6 more
TL;DR: PGF is a devastating postoperative complication, occurring in 15% of patients in the current series, and it is associated with a high mortality rate, lengthy hospitalization, and protracted and often compromised recovery among survivors.
Journal ArticleDOI
Pulmonary complications of solid organ and hematopoietic stem cell transplantation.
TL;DR: As the population of transplant recipients continues to grow and as their care progressively shifts from the university hospital to the community setting, knowledge of the pulmonary complications of transplantation is increasingly germane to the contemporary practice of pulmonary medicine.
Journal ArticleDOI
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients.
Donald E. Tsai,Christine Hardy,John E. Tomaszewski,Robert M. Kotloff,Kimberly M. Oltoff,Bradley G. Somer,Stephen J. Schuster,David L. Porter,Kathleen T. Montone,Edward A. Stadtmauer +9 more
TL;DR: Reduction in immunosuppression is an effective initial therapy for Posttransplant lymphoproliferative disorder and clinical prognostic factors may allow clinicians to identify which patients are likely to respond to reduction in immuno- suppression.